Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /SEQUENT
chevron_leftBack
Viyash Scientific Ltd. logo

Viyash Scientific Ltd.

SEQUENT
• NSE: SEQUENT • Delayed
203.74INR -1.7%
2.14 USD
As of 8 June 2026, Viyash Scientific Ltd. has a market cap of $948.71M USD, ranking #11035 globally and #599 in India. It ranks #999 in the Healthcare sector, and #53 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
11035
Country Rank
599
Sector Rank
999
Industry Rank
53
Key Stats
Market Cap
$948.71MUSD
90.48B INR
Enterprise Value
$1.0BUSD
95.45B INR
Revenue (TTM)
$190.54MUSD
18.17B INR
EBITDA (TTM)
$37.32MUSD
3.56B INR
Net Income (TTM)
$10.23MUSD
975.88M INR
EBITDA Margin
20%
Profit Margin
5.4%
PE Ratio
92.7
Forward PE
25.4
PS Ratio
5.0
PB Ratio
10.2
EV/EBITDA
26.3
Company Profile
Country (HQ)
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rajaram Narayanan open_in_new
Employees
1,244
Founded
1985
Website
viyash.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.7% -1.1% 11% 1.6% 0.5% 38%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
SEQUENT
Sequent Scientific Ltd
ISIN: INE807F01027
Shares Out.:
254.113M1 Shares Float: 254.113M2
TV:
NSE: SEQUENT
SA:
NSE: SEQUENT
YF:
SEQUENT.NS
GF:
NSE: SEQUENT
BA:
SEQUENT
MS:
XNSE: SEQUENT
203.74 INR
Bombay Stock Exchange
MIC: XBOM
512529 (VIYASH)
Sequent Scientific Ltd
ISIN: INE807F01027
Shares Out.:
436.463M1 Shares Float: 168.828M2
TV:
BSE: VIYASH
SA:
BOM: 512529
YF:
512529.BO
GF:
BOM: 512529
BA:
512529
MS:
XBOM: 512529
207.30 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Viyash Scientific Ltd.

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
PE
Cipla Ltd.
CIPLA
$11.16B
1.06T INR
1K%
23.4
Lupin Ltd.
LUPIN
$11.04B
1.05T INR
1K%
22.7
Aurobindo Pharma Ltd.
AUROPHARMA
$8.46B
807.02B INR
792%
23.1
Cohance Lifesciences Ltd.
SUVENPHAR
$1.88B
178.87B INR
98%
199.0
Granules India Ltd.
GRANULES
$1.83B
174.85B INR
93%
32.1
Sudeep Pharma Ltd.
SUDEEPPHRM
$820.51M
78.25B INR
-14%
45.0
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
Teva Pharmaceutical Industries Ltd.
TEVA
$37.66B
108.92B ILS
4K%
24.2
Revolution Medicines, Inc.
RVMD
$29.56B
3K%
-
Zhejiang NHU Company Ltd.
002001
$15.84B
107.34B CNY
2K%
16.0
Haisco Pharmaceutical Group Co., Ltd.
002653
$9.09B
61.6B CNY
858%
80.6
ABIVAX Société Anonyme
ABVX
$8.79B
7.57B EUR
826%
-
Dong-E-E-Jiao Co., Ltd.
000423
$5.21B
35.33B CNY
450%
20.0
chevron_leftBack